About Opsens

Fiber optic sensors manufacturer offering solutions for interventional cardiology Fractional Flow Reserve FFR, Oil and Gas and industrial applications.

Board of Directors

President, Chief Executive Officer / Louis Laflamme

Louis Laflamme became President, Chief Executive Officer and Director of Opsens in January 2013. He had been Chief Financial Officer and Corporate Secretary of the Company from November 2005 to January 2013. His main tasks are to define and execute the Company’s strategy both toward shareholders and the financial community in operational administrative activities. From March 2005 to November 2005, he was Director, Finance and Administration for DEQ Systems Corp. (TSXV:DEQ), a company manufacturing and distributing electronic systems for tables gambling. From 2002 to 2005, Mr. Laflamme held various positions within the administration department including that of Vice President Finance at TGN biotech inc., a company specializing in research and development in biotechnology. From January 2002 to July 2002, Mr. Laflamme also served as Corporate Controller at St-Raymond Forest Products Ltd., a company involved in the manufacturing of wood veneer. From 1998 to 2001, he was Chief of Mission in the department certification consulting for Samson Bélair / Deloitte & Touche LLP. Mr. Laflamme is a member of Quebec\’s Order of Chartered Professional Accountants since 2001. He received a BA in Business Administration from Université Laval in 1998.

Vice-President Opsens Medical / Claude Belleville

Claude Belleville is Vice-President, Medical since October 2006. His primary responsibilities are to oversee the medical sector‘s activities by orienting the main lines of commercial and intellectual property development, planning the work and implementing the Corporation’s action plan. In May 1994, he co-founded FISO Technologies Inc., a corporation manufacturing fiber optic sensors, where he acted as President from May 1994 to December 2002, then as Vice-President, R&D until August 2003. In addition to managing the Corporation, Mr. Belleville was responsible for the development of fiber optic sensors, and contributed to the development of fiber optic sensing products and technologies. Mr. Belleville obtained a Bachelor’s degree in Physical Engineering (Optics and Photonics) in 1986 and a Master’s degree in Optics from Université Laval in 1988.

Vice-President Opsens Solution / Gaétan Duplain

Gaétan Duplain is Vice-President, Oil & Gas since October 2006. His primary responsibilities are to oversee the energy sector’s research activities by orienting the main lines of commercial and intellectual property development, planning the work and implementing the Corporation’s action plan. In 1994, he co-founded FISO Technologies Inc., a company manufacturing fiber optic sensors, where acted as Vice-President from 1994 to 2003. With this company, Mr. Duplain acquired experience in high-tech business development and strategic planning. He obtained a Bachelor’s degree in Physical Engineering from Université Laval in 1985 and a Master’s degree in Optics and Laser from the same university in 1986.

Director / Denis Sirois

Denis M. Sirois has been Executive Vice-President of Exaclan Inc. since 1996 and Vice-President, Investments of Telesystem Ltd. since 2006, two private holding companies. Mr. Sirois sits on the Board of Telesystem Ltd., Exaclan Inc., Plexo Inc. and CJL Capital Inc. (TSXV:CJL). From 2006 to 2012, he sat on the Board of iPerceptions Inc. (TSXV:IPE), until its privatization and remained on its Board after. From August 2010 to March 2011, he was a board member of Innovente Inc. (TSXV:IGE). Mr. Sirois began his career with corporation Bureaux de crédit collectifs Ltée (BCCL), for which he became Managing Director in 1993. BCCL was a Québec leader in credit information systems and was sold to a multinational in 1996.

Director / Denis Harrington

Denis Harrington is the owner of Denis L Harrington Consulting, LLC a management and strategy consulting firm he established in December, 2012 after nearly 30 years of successful leadership roles in the US Army and the Medical Device Industry.

Most recently Denis served as CEO for BridgePoint Medical and successfully led BridgePoint from its development stage through commercialization and to successful acquisition by Boston Scientific in October, 2012.

Denis came to BridgePoint Medical from Boston Scientific where he spent 18 years. Denis last role at BSC was as Senior Vice-President of US Cardiology, Rhythm and Vascular Sales – managing over 1800 people and $3 billion in revenue.

Director / Jean Lavigueur, CA

Jean Lavigueur is, since 2006, Chief Financial Officer of Coveo Solutions Inc., a company working in the field of enterprise search engines. He was, from 2007 to 2012, director of iPerceptions Inc. (TSXV:IPE), a web-focused Customer analytics provider. He was Chairman of iPerceptions Inc.’s Audit Committee and President of the Special Committee of independent directors when the company was sold and privatized. Mr. Lavigueur served on the Board of Cossette Inc. (TSX: KOS) and was responsible for the audit committee and special committee of independent directors until December 2009, when the company was sold and privatized.

He was co-founder of Taleo Corporation (NASDAQ:TLEO), a public company providing management services and hiring talent on the Internet and was Chief Financial Officer from 1999 to 2005, after serving for few months, other roles, including Vice President, Finance.

From 1996 to 1999, he was Chief Financial Officer of Baan Supply Chain Solutions, a company specializing in the enterprise resource planning (ERP) and from 1991 to 1996, Chief Financial Officer of the Group Berclain inc., a firm specializing in management solutions for assembly lines that had subsequently been acquired by Baan. Prior to joining the Group Berclain inc. Mr. Lavigueur worked within divisions of audit and tax Coopers & Lybrand (now PriceWaterhouseCoopers SRL / LLP), a firm of public accountants. Mr. Lavigueur holds a B.A.A. from Université Laval and has been a certified professional accountant since 1986.

Director / Pat Mackin

Mr. Pat Mackin is President and Chief Executive Officer and Chairman of CryoLife, Inc. (NYSE:CRY) (“CryoLife”) since September 2014, a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures. CryoLife markets and sells products in more than 80 countries worldwide. Before joining CryoLife, from August 2007 to July 2014, he was President of the Cardiac Rhythm Disease Management Division at Medtronic, Inc. (NYSE:MDT) (“Medtronic”). From 2004 to 2006, also at Medtronic, he held the positions of Vice President, Vascular, Western Europe where he launched the Corporation’s first drug-eluting stent called “Endeavour” and Vice President and General Manager, Endovascular Business Unit. Prior to joining Medtronic, from 1996 to 2002, Mr. Mackin worked for six years at Genzyme, Inc., serving as Senior Vice President and General Manager for the Cardiovascular Surgery Business Unit and as Director of Sales, Surgical Products division. From 1991 to 1996, Mr. Mackin spent five years at Deknatel/Snowden-Pencer, Inc. in various sales and marketing roles and three years as an Officer in the U.S. Army. Mr. Mackin received an MBA from the Kellogg School of Management at Northwestern University and is a graduate of the United States Military Academy at West Point.